Radian (RDN) Q3 2026 Earnings Call Transcript

Radian reported Q3 2026 adjusted net operating EPS of $1.44, up 25% year over year, and revenue of $624 million, up 106% largely following the Inigo acquisition. Primary mortgage insurance in force reached a record $286 billion; Specialty adjusted pretax operating income was $86 million, supported by $43 million of favorable reserve development and a benign catastrophe quarter. Radian repurchased $135 million of shares in Q3 and another $117 million in October, bringing 2026 repurchases to $379 million, or 8% of beginning shares outstanding; management expects to refinance senior debt maturing in Q1 2027 and keep holding-company liquidity around $300 million to $400 million. Management cited competitive pressure in property and reinsurance and a seasonally rising mortgage default rate of 2.68%, while describing underlying credit performance as in line with expectations.

Analysis

The quarter’s headline earnings strength is less repeatable than the diversification story: Specialty benefited from benign catastrophe activity and $43 million of favorable reserve development, while management says underlying combined performance would have been in the low 90s. That points to solid underwriting, but investors should not annualize this quarter’s Specialty contribution. Competitive pricing is already showing up in lower earned premiums; further premium contraction without stable underlying loss ratios would undermine the Inigo earnings-diversification case.

Mortgage remains a cash generator, but reported loss experience is being helped by favorable reserve development, while seasoning and low refinancing extend exposure to older vintages. A credit-score or insurance-cancellation policy change is a longer-dated risk to new-business pricing and policy duration—not yet a basis to price in a specific earnings hit. For Fannie Mae and Freddie Mac, any redesign also trades lower borrower costs against the availability and pricing of private credit protection.

Near term, the buyback and completed debt repayment support per-share results, but buybacks are discretionary and compete with capital needs: the parent guarantee supports Inigo’s larger letter-of-credit facility, linking Specialty capacity more closely to group credit strength. Over 1–3 months, watch normalized Specialty combined ratio, earned-premium trends, MI defaults/cures, and the Q1 2027 refinancing. Over 6–18 months, the key question is whether Inigo generates distributable excess capital through a softer market. The contrarian point: reported growth is acquisition-led and the unusually favorable quarter may draw attention away from underwriting margins and capital fungibility.

Key Decisions for Investors

• RDN: avoid chasing the reported EPS beat; consider a staged long only on weakness below the latest reported $35.78 book value, and size it as a capital-return/earnings-diversification thesis rather than a clean organic-growth trade. Reassess if Specialty’s underlying combined ratio moves materially above the low-90s range or premiums continue to shrink without stable margins.
• For the next 1–3 months, track Specialty results excluding catastrophe benefits and reserve development, alongside gross written premiums. A deterioration in both would falsify the underwriting-discipline thesis; stable normalized ratios despite competitive-market premium pressure would strengthen it.
• Keep MI policy changes on alert, not in the base case: verify FHFA/GSE rules on AVM-based cancellation, effective dates, and RDN’s repricing response before underwriting any duration or earnings impact. Also monitor default cures and vintage-level loss data rather than extrapolating the aggregate default-rate increase.
• Before adding to RDN, verify the Q1 2027 refinancing terms and whether holding-company liquidity stays within management’s stated range as buybacks continue and the Inigo letter-of-credit facility supports 2027 capacity. No options trade is warranted without clearer catalysts and current pricing.